The impact of policy interventions to promote the uptake of biosimilar medicines in Belgium: a nationwide interrupted time series analysis

Background: The Belgian government has taken several measures to increase the uptake of biosimilars in past years. However, no formal evaluation of the impact of these measures has been made yet. This study aimed to investigate the impact of the implemented measures on biosimilar uptake. Methods: An interrupted time series analysis was performed using an autoregressive integrated moving average (ARIMA) model with the Box-Jenkins method. All data were expressed as defined daily doses (DDD) per month/quarter and obtained from the Belgian National Institute for Health and Disability Insurance (NI... Mehr ...

Verfasser: Vandenplas, Yannick
Simoens, Steven
Van Wilder, Philippe
Vulto, Arnold A.G.
Huys, Isabelle
Dokumenttyp: Artikel
Erscheinungsdatum: 2023
Schlagwörter: Science et gestion hospitalières / Santé publique / ARIMA / Belgium / Biological / Biosimilar / Interrupted time series / Policy
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-28957787
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/371320